-
1
-
-
0037058826
-
Lifetime risk for developing congestive heart failure: The Framingham Heart Study
-
DOI 10.1161/01.CIR.0000039105.49749.6F
-
Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D (2002) Lifetime risk for developing congestive heart failure: The Framingham heart study. Circulation 106(24):3068-3072 (Pubitemid 35440290)
-
(2002)
Circulation
, vol.106
, Issue.24
, pp. 3068-3072
-
-
Lloyd-Jones, D.M.1
Larson, M.G.2
Leip, E.P.3
Beiser, A.4
D'Agostino, R.B.5
Kannel, W.B.6
Murabito, J.M.7
Vasan, R.S.8
Benjamin, E.J.9
Levy, D.10
-
2
-
-
57149134513
-
Longterm trends in the incidence of heart failure after myocardial infarction
-
doi:10.1161/CIRCUL ATIONAHA.108.784215
-
Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Longterm trends in the incidence of heart failure after myocardial infarction. Circulation 118(20):2057-2062. doi:10.1161/CIRCUL ATIONAHA.108.784215
-
(2008)
Circulation
, vol.118
, Issue.20
, pp. 2057-2062
-
-
Velagaleti, R.S.1
Pencina, M.J.2
Murabito, J.M.3
Wang, T.J.4
Parikh, N.I.5
D'Agostino, R.B.6
Levy, D.7
Kannel, W.B.8
Vasan, R.S.9
-
3
-
-
0037336371
-
The EuroHeart Failure survey programme - A survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis
-
DOI 10.1016/S0195-668X(02)00823-0
-
Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The Euroheart failure survey programme- a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 24(5):442-463 (Pubitemid 36286187)
-
(2003)
European Heart Journal
, vol.24
, Issue.5
, pp. 442-463
-
-
Cleland, J.G.F.1
Swedberg, K.2
Follath, F.3
Komajda, M.4
Cohen-Solal, A.5
Aguilar, J.C.6
Dietz, R.7
Gavazzi, A.8
Hobbs, R.9
Korewicki, J.10
Madeira, H.C.11
Moiseyev, V.S.12
Preda, I.13
Van Gilst, W.H.14
Widimsky, J.15
Freemantle, N.16
Eastaugh, J.17
Mason, J.18
-
4
-
-
0037206364
-
Long-term trends in the incidence of and survival with heart failure
-
DOI 10.1056/NEJMoa020265
-
Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347(18):1397-1402. doi:10.1056/NEJMoa020265 (Pubitemid 35239711)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.18
, pp. 1397-1402
-
-
Levy, D.1
Kenchaiah, S.2
Glarson, M.3
Benjamin, E.J.4
Kupka, M.5
Ho, K.K.L.6
Murabito, J.M.7
Vasan, R.S.8
-
5
-
-
0027210870
-
Survival after the onset of congestive heart failure in Framingham Heart Study subjects
-
Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88(1):107-115 (Pubitemid 23195439)
-
(1993)
Circulation
, vol.88
, Issue.1
, pp. 107-115
-
-
Ho, K.K.L.1
Anderson, K.M.2
Kannel, W.B.3
Grossman, W.4
Levy, D.5
-
6
-
-
0030892967
-
Physicians' survival predictions for patients with acute congestive heart failure
-
Poses RM, Smith WR, McClish DK, Huber EC, Clemo FL, Schmitt BP, Alexander-Forti D, Racht EM, Colenda CC 3rd, Centor RM (1997) Physicians' survival predictions for patients with acute congestive heart failure. Arch Intern Med 157(9): 1001-1007 (Pubitemid 27190888)
-
(1997)
Archives of Internal Medicine
, vol.157
, Issue.9
, pp. 1001-1007
-
-
Poses, R.M.1
Smith, W.R.2
McClish, D.K.3
Huber, E.C.4
Clemo, F.L.W.5
Schmitt, B.P.6
Alexander-Forti, D.7
Racht, E.M.8
Colenda III, C.C.9
Centor, R.M.10
-
7
-
-
44249118880
-
Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events
-
DOI 10.1007/s00392-007-0629-2
-
Simon T, Becker R, Voss F, Bikou O, Hauck M, Licka M, Katus HA, Bauer A (2008) Elevated b-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events. Clin Res Cardiol 97(5):306-309. doi:10.1007/ s00392-007-0629-2 (Pubitemid 351725056)
-
(2008)
Clinical Research in Cardiology
, vol.97
, Issue.5
, pp. 306-309
-
-
Simon, T.1
Becker, R.2
Voss, F.3
Bikou, O.4
Hauck, M.5
Licka, M.6
Katus, H.A.7
Bauer, A.8
-
8
-
-
1442265576
-
B-Type Natriuretic Peptide - A Biomarker for All Seasons?
-
DOI 10.1056/NEJMe038233
-
Mark DB, Felker GM (2004) B-type natriuretic peptide-A biomarker for all seasons? N Engl J Med 350(7):718-720. doi: 10.1056/NEJMe038233 (Pubitemid 38364631)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.7
, pp. 718-720
-
-
Mark, D.B.1
Felker, G.M.2
-
9
-
-
0035204418
-
Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
-
DOI 10.1016/S0735-1097(01)01672-2, PII S0735109701016722
-
Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38(7):1934-1941 (Pubitemid 33116567)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.7
, pp. 1934-1941
-
-
Koglin, J.1
Pehlivanli, S.2
Schwaiblmair, M.3
Vogeser, M.4
Cremer, P.5
VonScheidt, W.6
-
10
-
-
34848907988
-
Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease [4]
-
DOI 10.1007/s00392-007-0562-4
-
Ndrepepa G, Braun S, Kastrati A, Schomig A (2007) Area under roc curve, sensitivity, specificity of n-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease. Clin Res Cardiol 96(10): 763-765. doi:10.1007/s00392-007-0562-4 (Pubitemid 47493074)
-
(2007)
Clinical Research in Cardiology
, vol.96
, Issue.10
, pp. 763-765
-
-
Ndrepepa, G.1
Braun, S.2
Kastrati, A.3
Schomig, A.4
-
11
-
-
33748072422
-
Raised B-type natriuretic peptide predicts implantable cardioverter- defibrillator therapy in patients with ischaemic cardiomyopathy [4]
-
DOI 10.1136/hrt.2005.076117
-
Klingenberg R, Zugck C, Becker R, Schellberg D, Heinze G, Kell R, Remppis A, Schoels W, Katus HA, Dengler TJ (2006) Raised b-type natriuretic peptide predicts implantable cardioverterdefibrillator therapy in patients with ischaemic cardiomyopathy. Heart 92(9):1323-1324. doi:10.1136/hrt.2005.076117 (Pubitemid 44298896)
-
(2006)
Heart
, vol.92
, Issue.9
, pp. 1323-1324
-
-
Klingenberg, R.1
Zugck, C.2
Becker, R.3
Schellberg, D.4
Heinze, G.5
Kell, R.6
Remppis, A.7
Schoels, W.8
Katus, H.A.9
Dengler, T.J.10
-
12
-
-
67049133604
-
Differential associations between renal function and " modifiable" risk factors in patients with chronic heart failure
-
doi:10.1007/s00392-008- 0732-z
-
Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL (2009) Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Cardiol 98(2):121-129. doi:10.1007/s00392-008- 0732-z
-
(2009)
Clin Res Cardiol
, vol.98
, Issue.2
, pp. 121-129
-
-
Smilde, T.D.1
Damman, K.2
Van Der Harst, P.3
Navis, G.4
Westenbrink, B.D.5
Voors, A.A.6
Boomsma, F.7
Van Veldhuisen, D.J.8
Hillege, H.L.9
-
13
-
-
30344446989
-
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: Determinants and detection of left ventricular dysfunction
-
DOI 10.1016/j.jacc.2005.09.025, PII S0735109705025684
-
Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr (2006) Amino-terminal pro-b-type natriuretic peptide and b-type natriuretic peptide in the general community: Determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47(2):345-353. doi:10.1016/j.jacc.2005.09.025 (Pubitemid 43063253)
-
(2006)
Journal of the American College of Cardiology
, vol.47
, Issue.2
, pp. 345-353
-
-
Costello-Boerrigter, L.C.1
Boerrigter, G.2
Redfield, M.M.3
Rodeheffer, R.J.4
Urban, L.H.5
Mahoney, D.W.6
Jacobsen, S.J.7
Heublein, D.M.8
Burnett Jr., J.C.9
-
14
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
DOI 10.1056/NEJMoa020233
-
Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA (2002) Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347(3):161-167. doi: 10.1056/ NEJMoa020233 (Pubitemid 34764819)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.3
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
McCord, J.4
Hollander, J.E.5
Duc, P.6
Omland, T.7
Storrow, A.B.8
Abraham, W.T.9
Wu, A.H.B.10
Clopton, P.11
Steg, P.G.12
Westheim, A.13
Knudsen, C.W.14
Perez, A.15
Kazanegra, R.16
Herrmann, H.C.17
McCullough, P.A.18
-
15
-
-
0034176934
-
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
-
Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355(9210):1126-1130 (Pubitemid 30172933)
-
(2000)
Lancet
, vol.355
, Issue.9210
, pp. 1126-1130
-
-
Troughton, R.W.1
Frampton, C.M.2
Yandle, T.G.3
Espiner, E.A.4
Nicholls, M.G.5
Richards, A.M.6
-
16
-
-
1342333833
-
NT-proBNP and BNP: Biomarkers for heart failure management
-
DOI 10.1016/j.ejheart.2004.01.008
-
Bettencourt P (2004) NT-proBNP and BNP: Biomarkers for heart failure management. Eur J Heart Fail 6(3):359-363. doi:10.1016/ j.ejheart.2004.01.008 (Pubitemid 38253058)
-
(2004)
European Journal of Heart Failure
, vol.6
, Issue.3
, pp. 359-363
-
-
Bettencourt, P.1
-
17
-
-
34247135389
-
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. The stars-bnp multicenter study
-
DOI 10.1016/j.jacc.2006.10.081, PII S0735109707008273
-
Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juilliere Y (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The stars-BNP multicenter study. J Am Coll Cardiol 49(16):1733-1739. doi:10. 1016/j.jacc.2006.10.081 (Pubitemid 46589928)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.16
, pp. 1733-1739
-
-
Jourdain, P.1
Jondeau, G.2
Funck, F.3
Gueffet, P.4
Le Helloco, A.5
Donal, E.6
Aupetit, J.F.7
Aumont, M.C.8
Galinier, M.9
Eicher, J.C.10
Cohen-Solal, A.11
Juilliere, Y.12
-
18
-
-
59249083643
-
Bnp-guided vs symptom-guided heart failure therapy: The trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIMECHF) randomized trial
-
doi:10.1001/ jama.2009.2
-
Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP (2009) Bnp-guided vs symptom-guided heart failure therapy: The trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIMECHF) randomized trial. JAMA 301(4):383-392. doi:10.1001/ jama.2009.2
-
(2009)
JAMA
, vol.301
, Issue.4
, pp. 383-392
-
-
Pfisterer, M.1
Buser, P.2
Rickli, H.3
Gutmann, M.4
Erne, P.5
Rickenbacher, P.6
Vuillomenet, A.7
Jeker, U.8
Dubach, P.9
Beer, H.10
Yoon, S.I.11
Suter, T.12
Osterhues, H.H.13
Schieber, M.M.14
Hilti, P.15
Schindler, R.16
Brunner-La Rocca, H.P.17
-
19
-
-
72549097700
-
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: Results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial
-
doi:10.1016/j.jacc.2009.02.095
-
Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM (2009) N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: Results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial. J Am Coll Cardiol 55(1): 53-60. doi:10.1016/j.jacc.2009.02.095
-
(2009)
J Am Coll Cardiol
, vol.55
, Issue.1
, pp. 53-60
-
-
Lainchbury, J.G.1
Troughton, R.W.2
Strangman, K.M.3
Frampton, C.M.4
Pilbrow, A.5
Yandle, T.G.6
Hamid, A.K.7
Nicholls, M.G.8
Richards, A.M.9
-
20
-
-
77955227797
-
Inflammation increases Nt-proBNP and the NT-proBNP/BNP ratio
-
doi: 10.1007/s00392-010-0140-z
-
Jensen J, Ma LP, Fu ML, Svaninger D, Lundberg PA, Hammarsten O (2010) Inflammation increases Nt-proBNP and the NT-proBNP/BNP ratio. Clin Res Cardiol 99(7):445-452. doi: 10.1007/s00392-010-0140-z
-
(2010)
Clin Res Cardiol
, vol.99
, Issue.7
, pp. 445-452
-
-
Jensen, J.1
Ma, L.P.2
Fu, M.L.3
Svaninger, D.4
Lundberg, P.A.5
Hammarsten, O.6
-
21
-
-
63449100423
-
Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation
-
doi:10.1007/s00392-009-0744-3
-
Hwang HJ, Son JW, Nam BH, Joung B, Lee B, Kim JB, Lee MH, Jang Y, Chung N, Shim WH, Cho SY, Kim SS (2009) Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Clin Res Cardiol 98(4):213-218. doi:10.1007/s00392- 009-0744-3
-
(2009)
Clin Res Cardiol
, vol.98
, Issue.4
, pp. 213-218
-
-
Hwang, H.J.1
Son, J.W.2
Nam, B.H.3
Joung, B.4
Lee, B.5
Kim, J.B.6
Lee, M.H.7
Jang, Y.8
Chung, N.9
Shim, W.H.10
Cho, S.Y.11
Kim, S.S.12
-
22
-
-
66149113693
-
The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age
-
doi:10.1136/hrt.2008.158626
-
Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JG, Katus HA, Zugck C (2009) The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95(10):825-829. doi:10.1136/hrt.2008.158626
-
(2009)
Heart
, vol.95
, Issue.10
, pp. 825-829
-
-
Frankenstein, L.1
Clark, A.L.2
Goode, K.3
Ingle, L.4
Remppis, A.5
Schellberg, D.6
Grabs, F.7
Nelles, M.8
Cleland, J.G.9
Katus, H.A.10
Zugck, C.11
-
23
-
-
50949104678
-
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
-
doi: 10.1016/j.jacc.2008.04.069
-
Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN (2008) Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 52(12):997-1003. doi: 10.1016/j.jacc.2008.04.069
-
(2008)
J Am Coll Cardiol
, vol.52
, Issue.12
, pp. 997-1003
-
-
Masson, S.1
Latini, R.2
Anand, I.S.3
Barlera, S.4
Angelici, L.5
Vago, T.6
Tognoni, G.7
Cohn, J.N.8
-
24
-
-
63849177462
-
2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation
-
doi:10.1016/j.jacc.2008.11.013
-
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol 53(15):e1-e90. doi:10.1016/j.jacc.2008.11.013
-
(2009)
J Am Coll Cardiol
, vol.53
, Issue.15
-
-
Hunt, S.A.1
Abraham, W.T.2
Chin, M.H.3
Feldman, A.M.4
Francis, G.S.5
Ganiats, T.G.6
Jessup, M.7
Konstam, M.A.8
Mancini, D.M.9
Michl, K.10
Oates, J.A.11
Rahko, P.S.12
Silver, M.A.13
Stevenson, L.W.14
Yancy, C.W.15
-
25
-
-
20544453277
-
Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005)
-
DOI 10.1093/eurheartj/ehi204
-
Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJ (2005) Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the European society of cardiology. Eur Heart J 26(11):1115-1140. doi:10.1093/eurheartj/ehi204 (Pubitemid 40839912)
-
(2005)
European Heart Journal
, vol.26
, Issue.11
, pp. 1115-1140
-
-
Swedberg, K.1
Cleland, J.2
Dargie, H.3
Drexler, H.4
Follath, F.5
Komajda, M.6
Tavazzi, L.7
Smiseth, O.A.8
Gavazzi, A.9
Haverich, A.10
Hoes, A.11
Jaarsma, T.12
Korewicki, J.13
Levy, S.14
Linde, C.15
Lopez-Sendon, J.-L.16
Nieminen, M.S.17
Pierard, L.18
Remme, W.J.19
-
26
-
-
53249090182
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the esc (HFA) and endorsed by the European society of intensive care medicine (ESICM)
-
doi:10.1093/eurheartj/ehn309
-
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the esc (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur Heart J 29(19):2388-2442. doi:10.1093/eurheartj/ehn309
-
(2008)
Eur Heart J
, vol.29
, Issue.19
, pp. 2388-2442
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
Stromberg, A.7
Van Veldhuisen, D.J.8
Atar, D.9
Hoes, A.W.10
Keren, A.11
Mebazaa, A.12
Nieminen, M.13
Priori, S.G.14
Swedberg, K.15
Vahanian, A.16
Camm, J.17
De Caterina, R.18
Dean, V.19
Funck-Brentano, C.20
Hellemans, I.21
Kristensen, S.D.22
Mcgregor, K.23
Sechtem, U.24
Silber, S.25
Tendera, M.26
Widimsky, P.27
Zamorano, J.L.28
more..
-
27
-
-
0029864693
-
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
-
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 world health organization/ international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93(5):841-842 (Pubitemid 26074816)
-
(1996)
Circulation
, vol.93
, Issue.5
, pp. 841-842
-
-
Richardson, P.1
McKenna, R.W.2
Bristow, M.3
Maisch, B.4
Mautner, B.5
O'Connell, J.6
Olsen, E.7
Thiene, G.8
Goodwin, J.9
Gyarfas, I.10
Martin, I.11
Nordet, P.12
-
28
-
-
65949114655
-
Variability of n-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables
-
doi:10.1373/clinchem.2008.112052
-
Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Slottje K, Katus HA, Zugck C (2009) Variability of n-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables. Clin Chem 55(5): 923-929. doi:10.1373/clinchem.2008.112052
-
(2009)
Clin Chem
, vol.55
, Issue.5
, pp. 923-929
-
-
Frankenstein, L.1
Remppis, A.2
Frankenstein, J.3
Hess, G.4
Zdunek, D.5
Slottje, K.6
Katus, H.A.7
Zugck, C.8
-
29
-
-
17744373270
-
N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction: A study in patients presenting with suspected cardiac disorders
-
DOI 10.1007/s00392-005-0205-6
-
Hess G, Moecks J, Zdunek D (2005) N-terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders. Z Kardiol 94(4):247-254. doi:10.1007/s00392-005-0205-6 (Pubitemid 40576519)
-
(2005)
Zeitschrift fur Kardiologie
, vol.94
, Issue.4
, pp. 247-254
-
-
Hess, G.1
Moecks, J.2
Zdunek, D.3
-
30
-
-
78649329479
-
Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure
-
doi:10.1007/ s00059-010-3377-4
-
Luers C, Schmidt A, Wachter R, Fritzsche F, Sutcliffe A, Kleta S, Zapf A, Hagenah G, Binder L, Maisch B, Pieske B (2010) Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure. Herz 35(7):488-495. doi:10.1007/ s00059-010-3377-4
-
(2010)
Herz
, vol.35
, Issue.7
, pp. 488-495
-
-
Luers, C.1
Schmidt, A.2
Wachter, R.3
Fritzsche, F.4
Sutcliffe, A.5
Kleta, S.6
Zapf, A.7
Hagenah, G.8
Binder, L.9
Maisch, B.10
Pieske, B.11
-
31
-
-
34247866537
-
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure
-
DOI 10.1016/j.jacc.2007.02.037, PII S0735109707007681
-
Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M (2007) Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49(19):1943-1950. doi:10.1016/j.jacc.2007.02.037 (Pubitemid 46694287)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.19
, pp. 1943-1950
-
-
Fonarow, G.C.1
Peacock, W.F.2
Phillips, C.O.3
Givertz, M.M.4
Lopatin, M.5
-
32
-
-
5644268954
-
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
-
DOI 10.1161/01.CIR.0000144310.04433.BE
-
Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110(15):2168-2174. doi:10.1161/01.CIR.0000144310. 04433.BE (Pubitemid 39372496)
-
(2004)
Circulation
, vol.110
, Issue.15
, pp. 2168-2174
-
-
Bettencourt, P.1
Azevedo, A.2
Pimenta, J.3
Frioes, F.4
Ferreira, S.5
Ferreira, A.6
-
33
-
-
0037432301
-
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
-
DOI 10.1161/01.CIR.0000054164.99881.00
-
Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan heart failure trial (Val-heft). Circulation 107(9):1278-1283 (Pubitemid 36314411)
-
(2003)
Circulation
, vol.107
, Issue.9
, pp. 1278-1283
-
-
Anand, I.S.1
Fisher, L.D.2
Chiang, Y.-T.3
Latini, R.4
Masson, S.5
Maggioni, A.P.6
Glazer, R.D.7
Tognoni, G.8
Cohn, J.N.9
-
34
-
-
34547756324
-
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial
-
DOI 10.1016/j.ejheart.2007.07.010, PII S1388984207002711
-
Olsson LG, Swedberg K, Cleland JG, Spark PA, Komajda M, Metra M, Torp-Pedersen C, Remme WJ, Scherhag A, Poole- Wilson P (2007) Prognostic importance of plasma nt-pro bnp in chronic heart failure in patients treated with a beta-blocker: Results from the carvedilol or metoprolol european trial (COMET) trial. Eur J Heart Fail 9(8):795-801. doi:10.1016/j.ejheart.2007. 07.010 (Pubitemid 47225165)
-
(2007)
European Journal of Heart Failure
, vol.9
, Issue.8
, pp. 795-801
-
-
Olsson, L.G.1
Swedberg, K.2
Cleland, J.G.F.3
Spark, P.A.4
Komajda, M.5
Metra, M.6
Torp-Pedersen, C.7
Remme, W.J.8
Scherhag, A.9
Poole-Wilson, P.10
-
35
-
-
66249125916
-
The prognostic value of repeated measurement of N-terminal pro- B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
-
doi:10.1093/eurjhf/hfp003
-
Kubanek M, Goode KM, Lanska V, Clark AL, Cleland JG (2009) The prognostic value of repeated measurement of N-terminal pro- B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11(4):367-377. doi:10.1093/eurjhf/hfp003
-
(2009)
Eur J Heart Fail
, vol.11
, Issue.4
, pp. 367-377
-
-
Kubanek, M.1
Goode, K.M.2
Lanska, V.3
Clark, A.L.4
Cleland, J.G.5
-
36
-
-
0347539775
-
Plasma b-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure
-
DOI 10.1161/01.CIR.0000106903.98196.B6
-
Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS (2003) Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108(24):2964-2966. doi:10.1161/ 01.CIR.0000106903.98196.B6 (Pubitemid 37553562)
-
(2003)
Circulation
, vol.108
, Issue.24
, pp. 2964-2966
-
-
Tang, W.H.W.1
Girod, J.P.2
Lee, M.J.3
Starling, R.C.4
Young, J.B.5
Van Lente, F.6
Francis, G.S.7
-
37
-
-
77955456594
-
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care
-
doi:10.1093/eurheartj/ehq163
-
Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, Januzzi J, Rosenberg J, Senior R, Richards M (2010) Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 31(15):1881-1889. doi:10.1093/eurheartj/ehq163
-
(2010)
Eur Heart J
, vol.31
, Issue.15
, pp. 1881-1889
-
-
Hildebrandt, P.1
Collinson, P.O.2
Doughty, R.N.3
Fuat, A.4
Gaze, D.C.5
Gustafsson, F.6
Januzzi, J.7
Rosenberg, J.8
Senior, R.9
Richards, M.10
-
38
-
-
0037531814
-
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population
-
Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F (2003) The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89(7):745-751 (Pubitemid 36760633)
-
(2003)
Heart
, vol.89
, Issue.7
, pp. 745-751
-
-
Raymond, I.1
Groenning, B.A.2
Hildebrandt, P.R.3
Nilsson, J.C.4
Baumann, M.5
Trawinski, J.6
Pedersen, F.7
-
39
-
-
34547629797
-
Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality
-
DOI 10.1373/clinchem.2006.084533
-
deFilippi CR, Seliger SL, Maynard S, Christenson RH (2007) Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 53(8):1511-1519. doi:10.1373/clinchem.2006.084533 (Pubitemid 47206349)
-
(2007)
Clinical Chemistry
, vol.53
, Issue.8
, pp. 1511-1519
-
-
DeFilippi, C.R.1
Seliger, S.L.2
Maynard, S.3
Christenson, R.H.4
-
40
-
-
7044284668
-
High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure
-
DOI 10.1373/clinchem.2004.038752
-
Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50(11):2052-2058. doi:10.1373/clinchem. 2004.038752 (Pubitemid 39425842)
-
(2004)
Clinical Chemistry
, vol.50
, Issue.11
, pp. 2052-2058
-
-
Bruins, S.1
Fokkema, M.R.2
Romer, J.W.P.3
Dejongste, M.J.L.4
Van Der Dijs, F.P.L.5
Van Den Ouweland, J.M.W.6
Muskiet, F.A.J.7
-
41
-
-
0041508543
-
Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure
-
DOI 10.1016/S0002-9149(03)00741-0
-
Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G (2003) Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92(5):628-631 (Pubitemid 37013426)
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.5
, pp. 628-631
-
-
Wu, A.H.B.1
Smith, A.2
Wieczorek, S.3
Mather, J.F.4
Duncan, B.5
White, C.M.6
McGill, C.7
Katten, D.8
Heller, G.9
-
42
-
-
0032736511
-
Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
-
Murdoch DR, McDonagh TA, Byrne J, Blue L, Farmer R, Morton JJ, Dargie HJ (1999) Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 138(6 Pt 1):1126-1132
-
(1999)
Am Heart J
, vol.138
, Issue.6 PART 1
, pp. 1126-1132
-
-
Murdoch, D.R.1
McDonagh, T.A.2
Byrne, J.3
Blue, L.4
Farmer, R.5
Morton, J.J.6
Dargie, H.J.7
-
43
-
-
5144232593
-
Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure
-
DOI 10.1016/j.healun.2004.07.006, PII S105324980400395X
-
Rothenburger M, Wichter T, Schmid C, Stypmann J, Tjan TD, Berendes E, Etz C, Pioux A, Loher A, Wenzelburger F, Drees G, Hoffmeier A, Breithardt G, Scheld HH (2004) Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 23(10):1189-1197. doi:10.1016/j.healun.2004.07.006 (Pubitemid 39346236)
-
(2004)
Journal of Heart and Lung Transplantation
, vol.23
, Issue.10
, pp. 1189-1197
-
-
Rothenburger, M.1
Wichter, T.2
Schmid, C.3
Stypmann, J.4
Tjan, T.D.T.5
Berendes, E.6
Etz, C.7
Pioux, A.8
Loher, A.9
Wenzelburger, F.10
Drees, G.11
Hoffmeier, A.12
Breithardt, G.13
Scheld, H.H.14
-
44
-
-
1242295182
-
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
-
DOI 10.1016/j.jacc.2003.09.044
-
Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43(4): 635-641. doi:10.1016/j.jacc.2003.09.044 (Pubitemid 38229537)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.4
, pp. 635-641
-
-
Logeart, D.1
Thabut, G.2
Jourdain, P.3
Chavelas, C.4
Beyne, P.5
Beauvais, F.6
Bouvier, E.7
Solal, A.C.8
-
45
-
-
33947139106
-
Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization
-
DOI 10.1016/j.ijcard.2006.06.004, PII S0167527306005031
-
Bettencourt P, Azevedo A, Fonseca L, Araujo JP, Ferreira S, Almeida R, Rocha-Goncalves F, Ferreira A (2007) Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. Int J Cardiol 117(1):75-79. doi:10.1016/j.ijcard.2006. 06.004 (Pubitemid 46399972)
-
(2007)
International Journal of Cardiology
, vol.117
, Issue.1
, pp. 75-79
-
-
Bettencourt, P.1
Azevedo, A.2
Fonseca, L.3
Araujo, J.P.4
Ferreira, S.5
Almeida, R.6
Rocha-Goncalves, F.7
Ferreira, A.8
-
46
-
-
14544270490
-
Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure
-
DOI 10.1373/clinchem.2004.041582
-
Miller WL, Hartman KA, Burritt MF, Borgeson DD, Burnett JC Jr, Jaffe AS (2005) Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure. Clin Chem 51(3):569-577. doi:10.1373/ clinchem.2004.041582 (Pubitemid 40300233)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.3
, pp. 569-577
-
-
Miller, W.L.1
Hartman, K.A.2
Burritt, M.F.3
Borgeson, D.D.4
Burnett Jr., J.C.5
Jaffe, A.S.6
-
47
-
-
33847021875
-
Longterm clinical variation of NT-proBNP in stable chronic heart failure patients
-
doi:10.1093/ eurheartj/ehl449
-
Schou M, Gustafsson F, Kjaer A, Hildebrandt PR (2007) Longterm clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J 28(2):177-182. doi:10.1093/ eurheartj/ehl449
-
(2007)
Eur Heart J
, vol.28
, Issue.2
, pp. 177-182
-
-
Schou, M.1
Gustafsson, F.2
Kjaer, A.3
Hildebrandt, P.R.4
-
48
-
-
0034332845
-
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
-
Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M (2000) High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36(5):1587-1593
-
(2000)
J Am Coll Cardiol
, vol.36
, Issue.5
, pp. 1587-1593
-
-
Maeda, K.1
Tsutamoto, T.2
Wada, A.3
Mabuchi, N.4
Hayashi, M.5
Tsutsui, T.6
Ohnishi, M.7
Sawaki, M.8
Fujii, M.9
Matsumoto, T.10
Kinoshita, M.11
|